{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:20:00Z","timestamp":1791930000465,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.atherosclerosis.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T01:00:59Z","timestamp":1484701259000},"page":"86-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Homozygous familial hypercholesterolemia: Summarized case reports"],"prefix":"10.1016","volume":"257","author":[{"given":"Kurt","family":"Widhalm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina Michel","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Helk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Kostner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Roeters van Lennep JE4, Stalenhoef AF, Wiegman A, de Graaf J, Fouchier SW, Kastelein JJ, Hovingh GK. Homozygous autosomal dominant hypercholesterolaemia in The Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"TESLA Investigators. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-3476(80)80024-2","article-title":"Successful plasmapheresis in a 4-year-old child with homozygous familial hypercholesterolemia","volume":"97","author":"Witztum","year":"1980","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpeds.2010.06.027","article-title":"Sudden death in a 4-year-old boy: a near-complete occlusion of the coronary artery caused by an aggressive low-density lipoprotein receptor mutation (W556R) in homozygous familial hypercholesterolemia","volume":"158","author":"Widhalm","year":"2011","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/bmj.291.6510.1671","article-title":"Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange","volume":"291","author":"Thompson","year":"1985","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000175431","article-title":"Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients","volume":"15","author":"Khachadurian","year":"1973","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9149(84)90298-4","article-title":"Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients","volume":"54","author":"Sprecher","year":"1984","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.01.002_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib11","first-page":"153","article-title":"Diagnostik und effiziente Therapie mittels Plasmapherese bei einem Patienten mit homozygoter famili\u00e4rer Hypercholesterin\u00e4mie","volume":"39","author":"Widhalm","year":"1984","journal-title":"Helv. Paed. Acta"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11789-012-0041-y","article-title":"Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R)","volume":"7","author":"Schaefer","year":"2012","journal-title":"Clin. Res. Cardiol. Suppl."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1365-2362.1998.00394.x","article-title":"A\u00a0novel low-density lipoprotein apheresis device for removal of atherogenic lipoproteins from whole blood","volume":"28","author":"Derfler","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib14","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/01.ATV.18.10.1600","article-title":"Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients","volume":"18","author":"Mak","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib15","first-page":"789","article-title":"Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene","volume":"57","author":"Koivisto","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1744-9987.2008.00574.x","article-title":"Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years","volume":"12","author":"Palcoux","year":"2008","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2015.01.007","article-title":"Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia","volume":"239","author":"Lefort","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1537-2995.2009.02135.x","article-title":"Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low-density lipoprotein apheresis","volume":"49","author":"Stefanutti","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/080352501750258793","article-title":"Low-density lipoprotein apheresis in a patient aged 3.5 years","volume":"90","author":"Stefanutti","year":"2001","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10545-007-0563-5","article-title":"Diagnosis of families with familial hypercholesterolaemia and\/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations","volume":"30","author":"Widhalm","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.transci.2013.05.001","article-title":"Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis","volume":"49","author":"Dann","year":"2013","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib23","doi-asserted-by":"crossref","unstructured":"Faiz F, Nguyen LT, van Bockxmeer FM, Hooper AJ. Genetic screening to improve the diagnosis of familial hypercholesterolemia. Clin. Lipidol. Vol. 9, No. 5, Pages 523\u2013532.","DOI":"10.2217\/clp.14.32"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib24","doi-asserted-by":"crossref","unstructured":"Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Koren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Stein EA; DESCARTES Investigators. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N. Engl. J. Med.. 201, 370:1809\u20131819. Epub 2014 Mar 29.","DOI":"10.1056\/NEJMoa1316222"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/clp.14.17","article-title":"Targeting MTP for the treatment of homozygous familial hypercholesterolemia","volume":"9","author":"Stefanutti","year":"2014","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Phase 3 HoFH Lomitapide Study investigators. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.01.002_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11883-014-0465-6","article-title":"Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances","volume":"17","author":"Stefanutti","year":"2015","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:50:47Z","timestamp":1568728247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":28,"alternative-id":["S0021915017300047"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.01.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homozygous familial hypercholesterolemia: Summarized case reports","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.02.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}